Compare Biogen Inc (BIIB) vs Match Group Inc (MTCH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Biogen Inc vs Match Group Inc — how do they compare? Biogen Inc trades at $202.7 (market cap $30.13B), while Match Group Inc trades at $36.82 (market cap $8.45B). The key difference: Biogen Inc is far larger — about 3.6× Match Group Inc's market cap, and Match Group Inc pays a 2.17% dividend while Biogen Inc pays none. Which is the better fit depends on your goals.
| BIIB | MTCH | |
|---|---|---|
Market Cap | $30.13B | $8.45B |
Sector | Health | Media |
52-Week High | $216.63 | $41.24 |
52-Week Low | $128.93 | $28.90 |
Enterprise Value | $37.20B | $11.42B |
Dividend Yield | — | 2.17% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Biogen Inc
Biogen and Idec merged in 2003, combining forces to market Biogen's multiple sclerosis drug Avonex and Idec's cancer drug Rituxan. Today, Rituxan and next-generation antibody Gazyva are marketed via a collaboration with Roche. Biogen also markets novel MS drugs Plegridy, Tysabri, Tecfidera, and Vumerity. In Japan, Biogen's MS portfolio is co-promoted by Eisai. Hemophilia therapies Eloctate and Alprolix (partnered with SOBI) were spun off as part of Bioverativ in 2017. Biogen has several drug candidates in phase 3 trials in neurology and neurodegenerative diseases and has launched Spinraza with partner Ionis. Aduhelm was approved as the firm's first Alzheimer's disease therapy in June 2021.
Read more on BIIB →About Match Group Inc
Match Group is a provider of online dating products. The firm became public in 2015 and was more than 80% owned by IAC/InterActiveCorp until IAC spun it off in the second quarter of 2020. The company has a vast portfolio of different online dating service providers, including Tinder, Match.com, OkCupid, Plenty of Fish, and Meetic. Match Group has more than 45 brands of online dating sites and/or apps, from which it generates user fee revenue (95%) and advertising revenue (5%).
Read more on MTCH →
